Regen Med. 2011 Jul;6(4):431-5. doi: 10.2217/rme.11.40.
Dr Haseltine speaks to Emily Culme-Seymour, Assistant Commissioning Editor William A Haseltine, PhD has an active career in both Science and Business. He was a professor at Harvard Medical School and Harvard School of Public Health (MA, USA) from 1976 to 1993, where he was Founder and Chair of two academic research departments. He is well known for his pioneering work on cancer, HIV/AIDS and genomics. He has authored more than 200 manuscripts in peer-reviewed journals and is the author of several books. He is the founder of Human Genome Sciences, Inc. and served as the Chairman and CEO of the company until 2004. He is also the founder of several other successful biotechnology companies. William Haseltine is currently Chairman and President of ACCESS Health International, Inc., which supports access to affordable, high-quality health services in low, middle and high income countries, and Chairman of the Haseltine Foundation for Science and the Arts, which fosters a dialog between sciences and the arts. He is an Adjunct Professor at the Scripps Institute for Medical Research and the Institute of Chemical Engineering, the University of Mumbai, India. He is a member of the Advisory Board of the IE University, Madrid, the President's Council of the Cold Spring Harbor Laboratory, the Advisory Council for the Koch Institute of MIT, a member of the University Council Committee on technology transfer, Yale University, and is a Lifetime Governor of the New York Academy of Science (NY, USA). He is an honorary member of the Board of Trustees of the Brookings Institution, a member of the Board of Trustees of the Center for Emerging Markets of the Indian School of Business, a member of the Council on Foreign Relations, a member of the Board of AID for AIDS International, and a member of the Chairman's Circle of the Asia Society. He is a member of the Advisory Board of the Metropolitan Opera (NY, USA), the Chairman's Council of the Metropolitan Museum (NY, USA), the International Council of the Guggenheim Museum, the International Council of the Tate Modern, the Board of Directors of the Young Concert Artists, Inc. and the Youth Orchestra of the Americas.
哈泽尔廷博士与艾米丽·卡尔梅-西摩尔交谈。威廉·A·哈泽尔廷博士在科学和商业领域都有着活跃的职业生涯。他曾于 1976 年至 1993 年在哈佛医学院和哈佛公共卫生学院（美国马萨诸塞州）担任教授，在那里他创立并担任两个学术研究部门的主席。他以在癌症、艾滋病毒/艾滋病和基因组学方面的开创性工作而闻名。他撰写了 200 多篇同行评议期刊上的论文，并著有几本书。他是人类基因组科学公司的创始人，并在 2004 年之前一直担任该公司的董事长兼首席执行官。他还是几家其他成功的生物技术公司的创始人。威廉·哈泽尔廷现任 ACCESS Health International, Inc. 的董事长兼总裁，该公司支持在低收入、中等收入和高收入国家提供负担得起的高质量医疗服务，并担任 Haseltine 科学与艺术基金会的主席，该基金会促进了科学与艺术之间的对话。他是斯克里普斯研究所医学研究和印度孟买大学化学工程研究所的兼职教授。他是马德里 IE 大学咨询委员会成员、冷泉港实验室总统理事会成员、麻省理工学院科赫研究所咨询委员会成员、耶鲁大学大学理事会技术转让委员会成员，也是纽约科学院（美国纽约州）终身州长。他是布鲁金斯学会董事会名誉成员、印度商学院新兴市场中心董事会成员、外交关系委员会成员、AID for AIDS International 董事会成员、亚洲协会主席圈成员。他是纽约大都会歌剧院（美国纽约州）咨询委员会成员、大都会艺术博物馆（美国纽约州）主席理事会成员、古根海姆博物馆国际理事会成员、泰特现代美术馆国际理事会成员、青年艺术家协会（美国纽约州）董事会成员和美洲青年管弦乐团董事会成员。
